An exhaustive account of frustrations, difficulties, and patient safety concerns came across loud and clear from more than 1,800 healthcare practitioners (68% pharmacists) who participated in our ...

Approximately one in three (35%) respondents reported that their facility had experienced a near miss during the past year due to a drug shortage. About one in four reported actual errors and one ...

The catheters were flushed daily with 0.2 ml sterile heparinized saline solution (0.6 or 0.3 ml of 1000 U/ml heparin in 30 ... from Supelco in 1-ml sealed vials in a concentration of ...

The content of the vial, after reconstituting with 12 ml sterile water for injection ... Blood anticoagulated with EDTA or Li-heparin (at NCL) was used to purify PBMC using Ficoll Paque gradient ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The recalled product, packaged in single dose 10ml vials, can be identified from its lot code, '24020027,' and expiry date, December 2025. It also has the national drug code (NDC) '81284-213-01.' ...

The Food and Drug Administration announced a recall last week of an injectable blood pressure drug used nationwide for treatment following anesthesia. The recall of the drug -- known as ...

Provepharm Inc. is conducting a voluntary nationwide recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL (Pharmacy ...

An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

The recalled product, packaged in single dose 10ml vials, can be identified from its lot code, '24020027,' and expiry date, December 2025. It also has the national drug code (NDC) '81284-213-01.' ...